Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Payam A Gammage

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
BMC Biology|July 10, 2019
Mitochondrial DNA: the overlooked oncogenome?Payam A Gammage, Christian Frezza
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2018
Enhanced Manipulation of Human Mitochondrial DNA Heteroplasmy In Vitro Using Tunable mtZFN TechnologyPayam A Gammage, Michal Minczuk
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2023
Coupling Differential Centrifugation with Exonuclease Treatment and Size Exclusion Chromatography (DIFSEC) for Purification of mtDNA from Mammalian CellsAndrew M Shaw, Payam A Gammage
Nucleic Acids Research|January 13, 2012
C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial ribosomeJoanna Rorbach, Payam A Gammage, Michal Minczuk
Nucleic Acids Research|October 22, 2015
C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial ribosomeJoanna Rorbach, Payam A Gammage, Michal Minczuk
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Engineered mtZFNs for Manipulation of Human Mitochondrial DNA HeteroplasmyPayam A Gammage, Lindsey Van Haute, Michal Minczuk
Trends in Genetics : TIG|November 29, 2017
Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-IzedPayam A Gammage, Carlos T Moraes, Michal Minczuk
Trends in Cancer|August 30, 2022
Mitochondrial DNA is a major source of driver mutations in cancerMinsoo Kim, Mahnoor Mahmood, Ed Reznik, et al.
Trends in Molecular Medicine|June 27, 2020
Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting PerspectiveChristopher B Jackson, Doug M Turnbull, Michal Minczuk, et al.
EMBO Molecular Medicine|February 26, 2014
Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutationsPayam A Gammage, Joanna Rorbach, Anna I Vincent, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
BMC Biology|July 10, 2019
Mitochondrial DNA: the overlooked oncogenome?Payam A Gammage, Christian Frezza
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2018
Enhanced Manipulation of Human Mitochondrial DNA Heteroplasmy In Vitro Using Tunable mtZFN TechnologyPayam A Gammage, Michal Minczuk
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2023
Coupling Differential Centrifugation with Exonuclease Treatment and Size Exclusion Chromatography (DIFSEC) for Purification of mtDNA from Mammalian CellsAndrew M Shaw, Payam A Gammage
Nucleic Acids Research|January 13, 2012
C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial ribosomeJoanna Rorbach, Payam A Gammage, Michal Minczuk
Nucleic Acids Research|October 22, 2015
C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial ribosomeJoanna Rorbach, Payam A Gammage, Michal Minczuk
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Engineered mtZFNs for Manipulation of Human Mitochondrial DNA HeteroplasmyPayam A Gammage, Lindsey Van Haute, Michal Minczuk
Trends in Genetics : TIG|November 29, 2017
Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-IzedPayam A Gammage, Carlos T Moraes, Michal Minczuk
Trends in Cancer|August 30, 2022
Mitochondrial DNA is a major source of driver mutations in cancerMinsoo Kim, Mahnoor Mahmood, Ed Reznik, et al.
Trends in Molecular Medicine|June 27, 2020
Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting PerspectiveChristopher B Jackson, Doug M Turnbull, Michal Minczuk, et al.
EMBO Molecular Medicine|February 26, 2014
Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutationsPayam A Gammage, Joanna Rorbach, Anna I Vincent, et al.
Pageof 4